Multicolor quantum dots aid in cancer biopsy diagnosis

Jul 06, 2010 by Quinn Eastman
Reed-Sternberg cells can be distinguished by their red outline, blue and white internal staining, and their lack of green staining. Credit: Shuming Nie

The tunable fluorescent nanoparticles known as quantum dots make ideal tools for distinguishing and identifying rare cancer cells in tissue biopsies, Emory and Georgia Tech scientists have demonstrated.

An article to be featured on the cover of the July 15 issue of describes how multicolor quantum dots linked to antibodies can distinguish the Reed-Sternberg cells that are characteristic of Hodgkin's lymphoma.

"Our multicolor quantum dot staining method provides rapid detection and identification of rare from heterogenous tissue specimens," says senior author Shuming Nie, PhD, the Wallace H. Coulter distinguished professor in the Coulter department of biomedical engineering at Georgia Tech and Emory University. "The clinical utility is not limited to Hodgkin's lymphoma but potentially could be extended to detect stem cells, tumor-associated macrophages and other rare cell types."

Quantum dots are nanometer-sized semiconductor crystals that have unique chemical and physical properties due to their size and their highly compact structure. Quantum dots can be chemically linked to antibodies, which can detect molecules present on the surfaces or internal parts of .

As a test of quantum dots' discriminatory power, the authors used four varieties at once -- white, red, green and blue - each detecting a different protein, to stain lymph node biopsies. The goal was to distinguish six Hodgkin's lymphoma cases from two other types of lymphoma and samples from two patients with benign growths in their lymph nodes.

Reed Sternberg cells have a distinctive appearance, but in lymph node tissue, they are usually surrounded by other . The authors describe identifying them as a task like "finding a needle in a haystack."

"We're excited about this technology," says Andrew Young, MD, PhD, associate professor of pathology and laboratory medicine at Emory University School of Medicine and director of clinical laboratories at Grady Health System. "We expect it could help guide the type of treatment a cancer patient gets and that it could be used with a wider variety of tumor types."

The most reliable way to assign cell identity is to look at more than one protein, Young says. With the standard methods in most pathology labs, staining cells with four different antibodies would require four separate slides - a problem when the specimen is very small. Small diagnostic specimens are common today, because they minimize the burden on the patient. In addition, the images from multiple separate slides wouldn't depict exactly the same cells. The allow "multiplexing": superimposing four colors on top of each other.

Hodgkin's lymphoma is usually treated with chemotherapy and radiation, and is notable among the subtypes of adult lymphoma because the survival rate is relatively high. Young says the quantum dot technique could be useful for other types of cancer, where distinguishing cancer cells based on surface or genetic markers can point oncologists towards "targeted therapies" designed for one particular type of tumor.

Explore further: 'Treasure in saliva' may reveal deadly diseases early enough to treat them

More information: J. Liu, S.K. Lau, V.A. Varma, B.A Kairdolf and S. Nie. Multiplexed detection of characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots. Anal. Chem. DOI:10.1021/ac101065b (online before print) 2010.

Related Stories

Mapping Tumor Heterogeneity With Quantum Dots

May 25, 2010

(PhysOrg.com) -- One important discovery made about cancer over the past decade is that as a tumor develops, the molecular identity of its cells begins to diverge. As a result, any given tumor is likely to contain groups ...

Evaluating Multiple Biomarkers With Quantum Dots

May 22, 2007

Quantum dots linked to biological molecules, such as antibodies, have shown promise as a new tool for detecting and quantifying a wide variety of cancer-associated molecules. Now, thanks to detailed studies of how to make ...

Promising treatment target found in Hodgkin lymphoma

Jul 31, 2007

Dana-Farber Cancer Institute scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells. Based on this finding, the researchers are now investigating ...

'Junk DNA' drives cancer growth

May 02, 2010

Researchers from the University of Leeds, UK, the Charite University Medical School and the Max Delbruck Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force behind cancer growth.

Recommended for you

'Swiss cheese' membrane with adjustable holes

7 hours ago

A new membrane, developed by University of Twente scientists, can be made more or less porous 'on demand'. In this way, smart switching between 'open' and 'closed' is possible, which opens the way to innovative ...

Stretching oxides to modulate electrochemical properties

9 hours ago

Solid oxide fuel cells and solid oxide electrolysis cells hold the promise of highly efficient energy conversion, with lower pollution, to meet increasing global energy demands. But these devices need good ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.